Objectives: To measure the diffusion of topical preparations of moxifloxacin, amphotericin B (AmB), and polyhexamethylene biguanide (PHMB) through silicone hydrogel (SH) contact lenses (CLs) in vitro. Methods: Using an in vitro model, the diffusion of three antimicrobials through SH CLs was measured. Diffused compounds were measured using a spectrophotometer at set time points over a period of 4 hr. The amount of each diffused antimicrobial was determined by comparing the experimental value with a standard curve. A biological assay was performed to validate the CL diffusion assay by testing antimicrobial activity of diffused material against lawns of susceptible bacteria (Staphylococcus epidermidis) and yeast (Saccharomyces cerevisiae). Experiments were repeated at least two times with a total of at least four independent replicates. Results: Our data show detectable moxifloxacin and PHMB diffusion through SH CLs at 30 min, whereas AmB diffusion remained below the limit of detection within the 4-hr experimental period. In the biological assay, diffused moxifloxacin demonstrated microbial killing starting at 20 min on bacterial lawns, whereas PHMB and AmB failed to demonstrate killing on microbial lawns over the course of the 60-min experiment.
T here are a multitude of therapeutic indications for soft contact lenses (CLs) in the management of ocular surface disorders.
Increasingly, silicone hydrogel (SH) materials are used for bandage lens purposes because of their higher oxygen permeability. Silicone hydrogel bandage CLs (BCLs) are employed to protect the cornea, increase patient comfort, facilitate healing, and provide mechanical support. [1] [2] [3] In clinical practice, therapeutic indications for BCLs include persistent epithelial defects (PEDs), primary disorders of the corneal epithelium, corneal dystrophies, postsurgical care of corneal refractive surgery or keratoplasty, trauma-related surface issues, bullous keratopathy, exposure keratopathy, and infectious keratitis. [4] [5] [6] [7] [8] [9] [10] The most common and convenient method for drug delivery to the eye is topical administration. Of all ophthalmic medications, 90% are applied to the ocular surface in the form of drops. 11, 12 Conventionally, an eyedropper is used to instill one drop into the inferior conjunctival cul-de-sac, where it resides for 3 to 5 min. [13] [14] [15] Most of the drug leaves the ocular surface through the lacrimal drainage system, and thus, the majority is systemically absorbed through the nasal mucosa. Only a small fraction of topically applied drug penetrates the ocular surface. Ghate and Edelhauser 16 reported that only 1% to 7% of topical drug instilled into the conjunctival sac is absorbed by the eye and reaches the aqueous humor. The corneal epithelium provides the largest biological barrier to penetration of applied topical drugs. The bioavailability of the drug is further reduced by precorneal factors, including lacrimal and accessory secretion, tear drainage, evaporation, and conjunctival absorption.
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In the management of corneal ulcers, therapeutic soft CLs are sometimes used to promote growth and healing of PEDs and to decrease patient suffering from painful infections. 17 In the context of concurrent use of hydrogel CLs, the lens itself acts as a barrier, and post-CLs tear film debris and tear exchange under the lens also affect how much time the drug is in contact with the eye. 18 Antimicrobial eyedrops are used concordantly with the BCLs, but there remains uncertainty as to how much and how quickly the drug penetrates through newer SH materials and thus how much medication is bioavailable to treat infection with the lens in place.
In a study published in 1984, McCarey et al. 19 determined that gentamicin, an aminoglycoside antibiotic and ophthalmic agent, is able to diffuse across traditional hydrogel bandage lenses. There is little known, however, about the penetration of other classes of antibiotics, including fluoroquinolones, which are frequently used in the treatment of bacterial corneal ulcers. Furthermore, there is no experimental or anecdotal evidence that topical antifungal and antiamoebic drug preparations are able to diffuse across BCLs. The issue of penetration of anti-infectives through BCLs has considerable clinical significance given the prevalence of their use in the management of bacterial, fungal, and amoebic infectious keratitis.
The purpose of this study was to investigate the diffusion of antiinfectives used in the treatment of and prophylaxis against microbial keratitis across SH CLs in vitro using ultraviolet (UV) spectrophotometry (primary outcome) and a biological assay (secondary outcome).
MATERIALS AND METHODS

Contact Lenses
Lotrafilcon A (Air Optix, Night and Day Aqua, CIBA Vision, Duluth, GA) SH CLs with the following specifications were used: base curve¼8.60, power¼20.25, diameter¼13.8 mm.
Antimicrobials
Representative antibacterial, antifungal, and antiamoebic agents, commonly used as ocular therapeutics, [20] [21] [22] respectively, used in this study are moxifloxacin (#M5794, LKT Laboratories, St. Paul, MN) dissolved in water with glacial acetic acid (6%) prepared at a concentration of 50 mg/mL, amphotericin B (AmB) (#A2411, Sigma, St. Louis, MO) dissolved in water at a concentration of 5 mg/mL, and polyhexamethylene biguanide (PHMB) (Baqua Spa, Zeneca Inc., Wilmington, DE) used directly from the purchased stock solution at a concentration of 200 mg/mL.
Contact Lens Diffusion Model Assay
The CL diffusion model is depicted in Figure 1 . Using sterile forceps, lotrafilcon A SH CLs were placed, concave side up, in the upper compartment of the Transwell six-well plates with 0.4 mm pore size filter (Costar 3412, Corning Inc., Corning, NY) allowing fluid exchange between the upper and lower chambers. One milliliter of phosphate-buffered saline (PBS) was added to the well of the test multiple well plate, which fills the lower chamber and saturates the filter but does not submerge the lens. Forty microliters (the approximate average volume contained in one drop of ophthalmic solution 13 ) of the test antimicrobials were added to the inner concavity of the CL. At set time points (1, 5, 10, 30, 60, 120, and 240 min), the transwell insert was removed, the PBS solution remaining in the well was mixed, and 20 mL of the solution was transferred to the 96-plate UV well (Costar 3635, Corning Inc.) into wells containing 180 mL of PBS. The solution was then assayed using a BioTek Synergy two microplate reader where absorbance for the solution was measured at the known UV absorbance maximum (Table 1) for the test antimicrobial using PBS as a blank. The amount of diffused antimicrobial was determined with a standard curve; in all cases, the R value was greater than 0.98 and measured values were within the linear range of the assay. Spectrophotometric analysis supported that in this system, moxifloxacin had a linear range of 0.5 to 50 mg/mL with a limit of detection 0.5 mg/mL. Polyhexamethylene biguanide had a linear range of 0.2 to 200 mg/mL with a limit of detection equal to 0.2 mg/mL. Amphotericin B was measured with a linear range from 0.61 to 625 mg/mL with a limit of detection of 0.61 mg/mL. Excel software (Microsoft, Redmond, WA) was used to establish a concentration-absorbance equation that was then used to determine experimental drug concentrations.
At least four independent replicates of the experiment were performed over 2 days for each of the drugs yielding similar results. All data and statistical analyses were performed with Microsoft Excel and Prism software (Graphpad, La Jolla, CA).
Biological Assay
A biological assay was designed to verify that tested antimicrobials were penetrating the CL and retained functionality. The CL diffusion model was performed as described previously (Fig. 1) ; however, at 10 min intervals over a 1-hr period, 10 mL aliquots of the diffused antibiotic were spotted onto lawns of susceptible test organisms. In this assay, Staphylococcus epidermidis strain RP62A was used for moxifloxacin and PHMB and Saccharomyces cerevisiae InvSc1 (Invitrogen, Carlsbad, CA) was used for AmB. Microbial cultures were grown overnight in Tryptic Soya Broth or yeast extract, peptone, and dextrose broth. Five microliters of overnight culture was added to 150 mL of PBS and plated onto nutrient-rich agar plates as a lawn and dried briefly before addition of the test aliquots. The plates were incubated overnight at 37°C for S. epidermidis and at 30°C for S. cerevisiae. Zones of growth inhibition were visually assessed. Prevention of microbial growth indicated that the antimicrobial was capable of diffusing through the SH CL applied directly onto the lawns. The sensitivity of the assay was established using a twofold serial dilution series of the test antimicrobials. The limit of detection was 4.88 mg/mL for moxifloxacin, 48.8 mg/mL for PHMB, and 39.1 mg/mL for AmB.
RESULTS
Three antimicrobials were chosen for use in the study based on several criteria: (1) common prescription practice in the management of infectious keratitis, (2) availability, (3) those with known maximum absorbance in UV spectra that were verified in previous experimental investigations, and (4) one representative drug from each class: antibacterial, antifungal, and antiamoebic.
Using the CL diffusion model assay, the penetration of moxifloxacin, PHMB, and AmB through SH CLs was measured over time (Fig. 2) . Moxifloxacin and PHMB diffusion were detectable at the 30-min time point and increased over time, whereas (Fig. 3B) , whereas PHMB and AmB did not reach sufficient concentrations to create zones of clearance on susceptible lawns of bacteria and yeast, respectively, over the 60-min period that samples were taken (Fig. 3C,D) . However, a small zone of inhibition, but not clearance, was seen with PHMB at 60 min (Fig.  3C ). This might be expected with the predicted 30 mg/mL of PHMB measured at 60 min (Fig. 2) coupled with the sensitivity of the biological assay at 49 mg/mL. Additionally, smaller molecular weight (MW) polymers of PHMB are less antimicrobial than larger MW molecules. 26, 27 It is possible that low MW polymers are passing through the CLs more readily accounting for the low levels of antimicrobial activity.
DISCUSSION
The influence of a CL on the surface of the eye is multifactorial; biochemical changes take place that alter the composition of the surface, 28 and there are biophysical interactions between the lens and tear film that alter the precorneal dynamics. 29 It is reasonable to assume that anything altering the surface dynamics of the ocular surface will also affect ocular penetration and bioavailability of the drug. As previously discussed, SH CLs are often used in the treatment of ocular surface disease, including infectious keratitis, in conjunction with topical antimicrobials. Infections of the cornea, however, sometimes persist despite frequent and aggressive topical anti-infective therapy in the presence of a BCL. In this study, in vitro diffusion assays demonstrated delayed and/or limited penetration of commonly used anti-infective agents through SH CLs.
According to our data, moxifloxacin and PHMB diffuse through SH CLs at detectable levels no sooner than 20 and 30 min, respectively, after adding the drug to the CL. This is significant The dark spot at the control location on the PHMB plate was not microbial growth, rather it was a precipitate formed whenever high levels of PHMB were applied to agar plates. AmB, amphotericin B; PBS, phosphate-buffered saline; PHMB, polyhexamethylene biguanide.
given that ophthalmic drugs without a CL purportedly remain on the ocular surface for only 3 to 5 min. 14, 15 Amphotericin B diffusion was undetectable at 4 hr using our experimental assays. In this in vitro study, the starting concentrations of each compound exceeded the therapeutic doses, to maximize the sensitivity of the assay. Moxifloxacin was used at 10 times higher than the most common commercial formulation (Vigamox), PHMB was used at 20% rather than the therapeutic dose of 0.02%, and AmB was used at 5,000 mg/mL compared with a typical standard dose of 1,500 mg/ mL. Even with these higher concentrations, the concentrations of drug that penetrated the CLs varied with respect to the standard therapeutic concentrations. Whereas the diffused concentration of PHMB achieved 411 mg/mL, approximately two times higher than the therapeutic concentration, both moxifloxacin (diffused concentration of 212 mg/mL vs. standard concentration of 5,000 mg/mL) and AmB (no measurable diffused drug compared with the standard concentration of 200 mg/mL) failed to achieve the levels found in topical formulations. The concentration of AmB that diffused through the CL was undetectable-far below the standard therapeutic concentration for this drug (1,500 mg/mL). As noted in Table 1 , the mass of AmB (923 Dalton) was larger than that of moxifloxacin (401 Dalton) or certain length polymers of PHMB (440-9,000 Dalton), and this may account for the reduced diffusion of AmB.
One limitation of this study was that we were not able to use clinical dosing concentrations of the antimicrobials because the concentrations had to be high enough for detection in the PBSfilled chamber below the lens. We expect that the lower concentrations used clinically would be expected to show even less diffusion. Additional limitations of this model are that it detects diffusion across CLs, but it neither directly addresses the concentrations of antibiotics achieved in the postlens tear film nor does it consider transport of antimicrobials around the lens and mixing with the postlens tear film.
Our study examined the diffusion of antimicrobials across SH CLs in vitro. Previous research using a kinetic model and computer-generated data to examine gentamicin distribution on the eye in the presence of a CL found that the amount of gentamicin that permeated through the CL was only 0.002% of the amount of gentamicin on the posterior aspect of the lens 10 min after topical application of the antibiotic. 19 This in vitro experimental model suggests that topical ophthalmic drugs, when applied in the presence of a CL, will move around the lens and that the diffusion through the lens may not be as important. 19 This model, however, fails to account for variation in fitting characteristics of a lens on the surface of the eye. Further studies in vivo are needed to explore the pharmacokinetics of topically administered medications when used in the context of BCL use.
